JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17976

Anti-MafA antibody

4

(7 Reviews)

|

(7 Publications)

Rabbit Polyclonal MAFA antibody. Suitable for WB, EMSA and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Mouse Mafa.

View Alternative Names

Transcription factor MafA, Pancreatic beta-cell-specific transcriptional activator, RIPE3b1 factor, V-maf musculoaponeurotic fibrosarcoma oncogene homolog A, MAFA

2 Images
Western blot - Anti-MafA antibody (AB17976)
  • WB

Unknown

Western blot - Anti-MafA antibody (AB17976)

Detection of MafA, MafB and cMaf by Western Blot. Samples : Nuclear extract (6 μg) from HeLa cells transfected with MafA, MafB or cMaf expression constructs. Antibodies : Affinity purified anti-MafA antibody, anti-MafB Antibody or anti-c-Maf antibody. Each antibody was used at 0.5 μg/ml. Detection : Chemiluminescence with a 5 second exposure.

All lanes:

Western blot - Anti-MafA antibody (ab17976)

Predicted band size: 36 kDa

false

Electrophoretic Mobility Shift Assay - Anti-MafA antibody (AB17976)
  • EMSA

Unknown

Electrophoretic Mobility Shift Assay - Anti-MafA antibody (AB17976)

Electrophoretic Mobility Shift of MafA, MafB and c-Maf. Samples : Nuclear extract (6 ug) from HeLa cells transfected with MafA, MafB or c-Maf expression constructs. Antibodies : Affinity purified anti-MafA antibody BL1069, anti-MafB Antibody or anti-c-Maf antibody.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, EMSA

applications

Immunogen

Synthetic Peptide within Mouse Mafa. The exact immunogen used to generate this antibody is proprietary information.

Q8CF90

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "EMSA" : {"fullname" : "Electrophoretic Mobility Shift Assay", "shortname":"EMSA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "EMSA-species-checked": "testedAndGuaranteed", "EMSA-species-dilution-info": "0.05-0.25 mg/mL", "EMSA-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "EMSA-species-checked": "predicted", "EMSA-species-dilution-info": "", "EMSA-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 - 8 Preservative: 0.1% Sodium azide Constituents: PBS, 1.815% Tris, 1.764% Sodium citrate
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MafA also known as musculoaponeurotic fibrosarcoma oncogene homolog A is a transcription factor with a molecular weight of approximately 43 kDa. This protein is expressed mainly in the pancreas particularly in the beta cells of the islets of Langerhans. MafA plays an important role in regulating insulin expression and secretion. High expression of MafA occurs during late-stage beta cell development making it an important marker for mature beta cells. Researchers often study MafA using techniques such as frozen tissue examination and flow cytometry with antibodies against MafA being important tools in these applications.
Biological function summary

MafA controls insulin gene transcription and supports beta cell function and survival. MafA does not function alone; it often forms complexes with other transcription factors like Pdx1 and NeuroD1 facilitating a coordinated regulation of insulin production and secretion. Its activity importantly aligns with the regulation of glucose metabolism responding to changes in glucose levels to ensure proper insulin release from the pancreas. In addition to its standalone role MafA synergizes with other transcription factors to modulate the expression of genes important to the maintenance of beta cell identity and function.

Pathways

The expression and function of MafA are integral to the insulin secretion pathway and the glucose homeostasis pathway. MafA operates alongside proteins like Pdx1 which also regulates insulin gene expression. The interplay between MafA and Pdx1 ensures appropriate response and adaptation of pancreatic beta cells to metabolic demands. Additionally the Wnt signaling pathway may intersect with MafA activity influencing beta cell proliferation and survival. Understanding these pathways is key to grappling with their impact on metabolic health and disease.

MafA closely relates to diabetes mellitus particularly type 2 diabetes. Dysfunction or altered expression of MafA impairs insulin production contributing significantly to the pathogenesis of this disorder. Another protein Nkx6.1 often shows disrupted expression alongside MafA in diabetic conditions exacerbating issues in insulin regulation. Furthermore MafA mutations or misregulation may also contribute to gestational diabetes where its interaction with other transcription factors becomes impaired affecting insulin secretion during pregnancy. Researchers continue to study these relationships to develop therapeutic strategies targeting MafA for diabetes management.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that activates insulin gene expression (PubMed : 12011435, PubMed : 15993959). Acts synergistically with NEUROD1/BETA2 and PDX1 (PubMed : 15993959). Binds the insulin enhancer C1/RIPE3b element (PubMed : 12011435). Binds to consensus TRE-type MARE 5'-TGCTGACTCAGCA-3' DNA sequence (PubMed : 23148532, PubMed : 29339498).
See full target information MAFA

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Molecular therapy. Methods & clinical development 28:355-365 PubMed36879848

2023

Specific reprogramming of alpha cells to insulin-producing cells by short glucagon promoter-driven Pdx1 and MafA.

Applications

Unspecified application

Species

Unspecified reactive species

Ping Guo,Ting Zhang,Aiping Lu,Chiyo Shiota,Matthieu Huard,Kaitlyn E Whitney,Johnny Huard

Brazilian journal of medical and biological resear 51:e7312 PubMed29846411

2018

MAFB mediates the therapeutic effect of sleeve gastrectomy for obese diabetes mellitus by activation of FXR expression.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Xu,Yong Wang,Jiajun Yin,Min Yin,Mofei Wang,Jingang Liu

Journal of neuroendocrinology 29: PubMed27891681

2016

Incomplete Re-Expression of Neuroendocrine Progenitor/Stem Cell Markers is a Key Feature of β-Cell Dedifferentiation.

Applications

Unspecified application

Species

Unspecified reactive species

A Neelankal John,G Morahan,F-X Jiang

The Journal of biological chemistry 291:16221-30 PubMed27226575

2016

Protein Kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Promotes Obesity-induced Hyperinsulinemia.

Applications

IHC-P

Species

Mouse

Rachel J Roth Flach,Laura V Danai,Marina T DiStefano,Mark Kelly,Lorena Garcia Menendez,Agata Jurczyk,Rohit B Sharma,Dae Young Jung,Jong Hun Kim,Jason K Kim,Rita Bortell,Laura C Alonso,Michael P Czech

Nature chemical biology 10:141-8 PubMed24316738

2013

VMAT2 identified as a regulator of late-stage β-cell differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Daisuke Sakano,Nobuaki Shiraki,Kazuhide Kikawa,Taiji Yamazoe,Masateru Kataoka,Kahoko Umeda,Kimi Araki,Di Mao,Shirou Matsumoto,Naomi Nakagata,Olov Andersson,Didier Stainier,Fumio Endo,Kazuhiko Kume,Motonari Uesugi,Shoen Kume

PloS one 8:e64472 PubMed23691228

2013

Identification and characterization of poorly differentiated invasive carcinomas in a mouse model of pancreatic neuroendocrine tumorigenesis.

Applications

WB, IHC-P

Species

Mouse, Mouse

Karen E Hunter,Marsha L Quick,Anguraj Sadanandam,Douglas Hanahan,Johanna A Joyce

PloS one 6:e22364 PubMed21857924

2011

TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology.

Applications

WB

Species

Mouse

Nancy Vargas,Silvia Álvarez-Cubela,Jaime A Giraldo,Margarita Nieto,Nicholas M Fort,Sirlene Cechin,Enrique García,Pedro Espino-Grosso,Christopher A Fraker,Camillo Ricordi,Luca Inverardi,Ricardo L Pastori,Juan Domínguez-Bendala
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com